Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model
- PMID: 3361431
- DOI: 10.1002/jps.2600770213
Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model
Abstract
The mean transit time (MTT) and the mean residence time (MRT) values of a linear two-compartment plasma clearance model were evaluated using definitions originally proposed by Rescigno and Gurpide. The MRT of the total body (MRTB) can be viewed as comprising the MRT in the central compartment (MRTC) and the MRT in the peripheral tissue compartment (MRTT). The MTT and MRT of each compartment can be envisioned as the average interval of time spent by a drug particle during a single passage and in all passages through it. Hence, the MRT is the product of MTT and the mean number of passages of a drug particle through the central (R + 1) or tissue (R) compartments. Physiologically, each MTT parameter is related to its apparent volume divided by all its clearance processes, reversible and irreversible (if any exist). Each MRT parameter is related to its apparent volume divided by only the sum of irreversible exit clearances. Applications of the five MTT/MRT parameters were made to disposition data for digoxin and gentamicin to assess their use as indicators of tissue persistency. This report provides additional physiological and pharmacokinetic insights into the disposition properties of drugs and reconciles various treatments of the two-compartment model using rate constants, volume/clearance terms, and transit/residence times.
Similar articles
-
Types of mean residence times.Biopharm Drug Dispos. 1988 Jan-Feb;9(1):41-57. doi: 10.1002/bod.2510090106. Biopharm Drug Dispos. 1988. PMID: 3342284
-
Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.Pharm Res. 1991 Apr;8(4):508-11. doi: 10.1023/a:1015811514050. Pharm Res. 1991. PMID: 1871048
-
Mean residence time of drugs administered non-instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non-linear elimination from the central compartment.Biopharm Drug Dispos. 1995 May;16(4):259-67. doi: 10.1002/bdd.2510160402. Biopharm Drug Dispos. 1995. PMID: 7548775
-
Interplay of transporters and enzymes in drug and metabolite processing.Mol Pharm. 2009 Nov-Dec;6(6):1734-55. doi: 10.1021/mp900258z. Mol Pharm. 2009. PMID: 19891494 Review.
-
Effects of bladder resorption on pharmacokinetic data analysis.J Pharmacokinet Biopharm. 1994 Jun;22(3):183-205. doi: 10.1007/BF02353328. J Pharmacokinet Biopharm. 1994. PMID: 7884649 Review.
Cited by
-
Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation.Eur J Clin Pharmacol. 1994;46(4):325-32. doi: 10.1007/BF00194400. Eur J Clin Pharmacol. 1994. PMID: 7957517
-
A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter fd in Physiologically Based Pharmacokinetics.J Pharm Sci. 2024 Jan;113(1):95-117. doi: 10.1016/j.xphs.2023.05.019. Epub 2023 Jun 4. J Pharm Sci. 2024. PMID: 37279835 Free PMC article.
-
Pharmacokinetic Assessment of Cooperative Efflux of the Multitargeted Kinase Inhibitor Ponatinib Across the Blood-Brain Barrier.J Pharmacol Exp Ther. 2018 May;365(2):249-261. doi: 10.1124/jpet.117.246116. Epub 2018 Feb 12. J Pharmacol Exp Ther. 2018. PMID: 29440450 Free PMC article.
-
Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.Clin Pharmacokinet. 1992 Jul;23(1):10-29. doi: 10.2165/00003088-199223010-00002. Clin Pharmacokinet. 1992. PMID: 1617856 Review.
-
Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy.Drug Metab Dispos. 2019 Dec;47(12):1403-1414. doi: 10.1124/dmd.119.088716. Epub 2019 Oct 16. Drug Metab Dispos. 2019. PMID: 31619389 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources